MicroRNA 4296 (MIR4296)

MicroRNA 4296 (MIR4296, hsa-mir-4296) is a predicted human microRNA listed in sequence databases as a non-coding, endogenous small RNA molecule, typically 20–24 nucleotides in length. MicroRNAs as a class regulate gene expression post-transcriptionally, mainly by binding to the 3' untranslated regions of mRNAs to inhibit translation or cause mRNA degradation[1][2]. However, there is no evidence in the biomedical literature that microRNA 4296 itself is functionally characterized, associated with a known disease role, or acts as a therapeutic target, nor is it discussed as a biomarker or drug-interaction partner. Context and supporting details: - The general features of microRNAs are well described: they are non-coding regulatory RNAs involved in controlling gene expression and modulate processes such as proliferation, apoptosis, differentiation, and cell cycle[1][2][4]. - Many microRNAs are established disease biomarkers or play confirmed roles in disease, especially cancer, but comprehensive reviews of microRNAs associated with molecular classification or therapy do not mention MIR4296[3][4][5]. - MIR4296 has an official symbol but does not appear in curated databases of functionally characterized or clinically validated miRNAs, and specific functional data (targets, disease roles, pathways) are lacking based on the provided literature. Reason for 'is_incorrect: true': - There is no current evidence supporting microRNA 4296 as a functionally validated or therapeutically relevant target; its presence in miRNA databases does not indicate functional characterization. - No information was found on disease associations, biological function, interacting drugs, mechanism of action, or biomarker use for MIR4296. - Thus, while the name itself is not misspelled, the assumption that it is a meaningful therapeutic target or that sufficient information exists for structured annotation is not correct based on present knowledge.

Other names

hsa-mir-4296MIR4296microRNA 4296